Results 191 to 200 of about 6,086,830 (296)
Trustworthy Agentic AI in Bioinformatics: From Workflow Automation to Traceable and Validated Biological Inference. [PDF]
Ang MY +4 more
europepmc +1 more source
ABSTRACT Objectives We aimed to determine the frequency of subclinical optic nerve (ON) lesions using MRI, optical coherence tomography (OCT), and visual evoked potentials (VEP) in radiologically isolated syndrome (RIS), and to assess their diagnostic and prognostic significance.
Christine Lebrun‐Frenay +13 more
wiley +1 more source
Towards a research renaissance: Empowering early career researchers through mentored AI use. [PDF]
Call DR +3 more
europepmc +1 more source
ABSTRACT Objective Neurochemical levels measured by brain MR spectroscopy (MRS) have been proposed as endpoints for clinical trials in early‐stage spinocerebellar ataxia (SCA) trials. We tested their trial‐readiness by quantifying neurochemicals in three affected brain regions in early‐stage cohorts of SCA2 and SCA3, examining their reproducibility in ...
James M. Joers +19 more
wiley +1 more source
AI and authorship: Norms and uses to preserve human-led science. [PDF]
Branas CC, Levine BL.
europepmc +1 more source
Booklet on the outputs of scientific exchanges
Booklet on the outputs of the short term scientific exchanges containing lists of lectures given by the trained personnel and other outputs of the scientific exchanges contribution to scientific conferences workshopsJustification Exchanges have been interrupted because of the Covid19 Whenever it is possible collaborations that were interrupted will be ...
openaire +1 more source
Digital Cognitive Testing in Mitochondrial Disease: Validity and Challenges for Clinical Trial Use
ABSTRACT Background Primary mitochondrial disease is a group of genetic disorders caused by pathogenic variants in nuclear or mitochondrial DNA, often resulting in progressive neurodegeneration and cognitive decline. Current management is primarily supportive, though recent research offers hope for disease‐modifying treatments in the future.
Oksana Pogoryelova +9 more
wiley +1 more source
ABSTRACT Objective Building on our prior Behavioral Risk Factor Surveillance System analysis identifying adults aged 18–39 as the primary driver of the national increase in self‐reported cognitive disability, we examined factors associated with this rise using 2013–2024 U.S. BRFSS data. Methods We analyzed U.S.
Adam de Havenon +9 more
wiley +1 more source
How publish-or-perish culture drives evidence fragmentation in oncology. [PDF]
Chau MT +5 more
europepmc +1 more source

